MedPath

Pyrosequencing of the BRAFV600E Mutation

Completed
Conditions
Thyroid Neoplasms
Registration Number
NCT00551486
Lead Sponsor
Chungnam National University
Brief Summary

To investigate the diagnostic efficiency of pyrosequencing for the mutant BRAF allele in ultrasound (US)-guided fine needle aspiration biopsies (FNAB) of thyroid incidentalomas.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
101
Inclusion Criteria
  • Patients with thyroid nodule larger than 1 cm, or nodule smaller than 1 cm that required further evaluation because of suspicious ultrasound findings
Exclusion Criteria
  • Patients who refuse participation.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chungnam National University Hospital

🇰🇷

Daejeon, Korea, Republic of

Chungnam National University Hospital
🇰🇷Daejeon, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.